A clinical formulation indicated for Neurology applications. Providing targeted relief for migraine symptoms, this option facilitates the constriction of blood vessels in the brain to provide comfort.
Designed to alleviate acute migraine pain by addressing vascular changes in the brain to support symptom relief and mitigate sensitivity to light and sound.
Mechanism of Action
Zolmitriptan acts on serotonin receptors to narrow blood vessels in the brain that have become too wide during a migraine. It also reduces the release of natural substances that cause pain and inflammation.
Route of Administration
Oral
Onset Time
45–60 minutes
Duration
Up to 24 hours
Contraindications
Ischemic heart disease, Uncontrolled hypertension, History of stroke, Hemiplegic migraine, Use of MAOIs
Severe Adverse Events
Heart attack, Severe hypertension, Serotonin syndrome, Stroke, Intestinal ischemia
Information for Zolmitriptan is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
